The TMT Analytics report published 17 April contains this "Given that the Prizma and the GMP have received Green Channel approval in China (an expedited approval process), GMV expects the relevant CFDA approvals to be obtained in 2Q18."
From what I've heard from the AGM this probably won't be the case and Q3 is more realistic. I know we want it to be this month, or this quarter, but I just don't see it happening.
To be fair, the dates are not something GMV can predict accurately. As to the communications around the release - personally I think they've been over promising by committing to timelines. It wasn't that long ago Yacov said it would be done in April.
It will come - and when it does, the register will be very tight.
GMV Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
